MONTREAL, QUEBEC–(Marketwired – Aug. 14, 2017) – Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, announced today [...]
MONTREAL, QUEBEC–(Marketwired – Aug. 14, 2017) – PyroGenesis Additive, a division of PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX VENTURE:PYR) (OTCQB:PYRNF), a […]